(Q37344738)

English

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

10

object named as

Saul Shiffman

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Jennifer W Tidey

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Peter M Monti

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Damaris J Rohsenow

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Chad J Gwaltney

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Robert Miranda

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

John E McGeary

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

James MacKillop

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Robert M Swift

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

David B Abrams

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jean A Paty

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

20 November 2007

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

58-66

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

What place does naltrexone have in the treatment of alcoholism?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Models for longitudinal data: a generalized estimating equation approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Naltrexone in the treatment of alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

6 September 2017

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

28 September 2017

A digest of memory phenomena for addiction research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

28 September 2017

Effects of naltrexone on alcohol self-administration in heavy drinkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

26 June 2018

Mu opioid receptor gene variants: lack of association with alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

26 June 2018

DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

26 June 2018

Naltrexone increases the latency to drink alcohol in social drinkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

26 June 2018

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

The effect of olanzapine on craving and alcohol consumption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

The DRD4 VNTR polymorphism moderates craving after alcohol consumption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Using acquired knowledge and new technologies in alcoholism treatment trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Predicting treatment response to naltrexone: the influence of craving and family history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Naltrexone's effects on reactivity to alcohol cues among alcoholic men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Non-specific effect of naltrexone on ethanol consumption in social drinkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Naltrexone's effect on cue-elicited craving among alcoholics in treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

A day at a time: predicting smoking lapse from daily urge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Remember that? A comparison of real-time versus retrospective recall of smoking lapses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Family history models of alcoholism: age of onset, consequences and dependence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Development and validation of the Biphasic Alcohol Effects Scale.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Naltrexone-induced alterations in human ethanol intoxication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743136

2 September 2018

Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of a family tree questionnaire for assessing family history of alcohol problems

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple non-invasive method to obtain DNA for gene analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone in the treatment of alcohol dependence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained-release naltrexone for alcoholism treatment: a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking

1 reference

https://pubmed.ncbi.nlm.nih.gov/18028530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1530-0277.2007.00545.X

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37344738&oldid=1942026836"